Correction to: Real-World Clinical Practice Use of 8-Week Glecaprevir/Pibrentasvir in Treatment-Naïve Patients with Compensated Cirrhosis (Advances in Therapy, (2020), 37, 9, (4033-4042), 10.1007/s12325-020-01449-0)